Neurology® Podcast

Explore neuroimaging findings in substance use disorders and the implications for therapeutic interventions. Learn about brain network associations and mapping to identify positive and negative nodes. Discover strategies for advancing research on neurostimulation trials in substance use disorders.

Topics discussed include global initiatives on rare neuroimmune conditions like NMOSD and MOGAD, raising awareness and advocating for patients, the lack of support and access to therapies in many countries, the success of the Global Ambassadors for NMO program, resources and community for NMO SD patients, and the motivation to make a positive impact on less privileged communities worldwide.

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org

Dr. Andy Southerland talks with Dr. Jonathan Coutinho about the accuracy of using EEG in the detection of large vessel occlusion stroke in prehospital settings. Read the related article in Neurology. Disclosures can be found at Neurology.org

Dr. Karin Diserens talks about subtle clinical signs in brain-impaired individuals. Dr. David Greer discusses updated brain death guidelines. Dr. Monica Lemmon focuses on communicating neurologic prognosis. Drs. Susanne Muehlschlegel and Adeline Goss talk about prognostic language in critical neurologic illness.

Our 2023 November Headache series wraps up with Dr. Tesha Monteith talking with Dr. Stewart Tepper about rapid developments in neuromodulation. Disclosures can be found at Neurology.org

Dr. Tesha Monteith and Dr. Peter Goadsby discuss updates on migraine treatments and the integration of CGRP inhibitors into clinical practice, including challenges in prescribing and switching prophylactic therapy. They also compare the effectiveness of G-PANs and trip tans, emphasize the importance of equitable access to treatments, and discuss reasons to be hopeful about the future of migraine treatments.

Dr. Tesha Monteith and Dr. Messoud Ashina discuss the mechanisms of migraines, including genetic factors, estrogen and neuropeptide interactions, and the challenges of CGRP inhibitor treatment. The podcast also explores the potential of pack-up as a treatment target and highlights recent breakthroughs in migraine research.

Dr. Andrew Southerland talks with Dr. Seemant Chaturvedi about exciting new trials that have come out in the world of stroke that were presented at this year's World Stroke Congress. Read more on the World Stroke Congress page. Disclosures can be found at Neurology.org

Drs. Deb Friedman and Kathleen Digre discuss idiopathic intracranial hypertension, weight loss challenges, surgical interventions like venous sinus stenting, alternative diuretics, management of low pressure headaches, and the importance of collaboration with other specialists.